The technology is an immunoassay based on monoclonal antibodies, which is intended for early detection of the capsular antigen associated with B. anthracis—the anthrax bacterium.
Our technology is a room temperature stable, orally delivered live attenuated PA antigen-based anthrax vaccine (AR 100) that is packaged in a convenient quick dissolving thin film. The vaccine vect...